Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cannabis and its primary psychoactive component, delta-9-tetrahydrocannabinol (THC), have documented effects on the dopaminergic system in the brain. Scientific studies have shown that acute cannabis use can transiently increase dopamine release, particularly in the striatum, which is associated with the brain's reward system. This underlies some of the euphoria and reinforcing effects of cannabis. However, evidence does not robustly support cannabis as a therapeutic agent specifically for supporting or enhancing the dopamine system in a clinical or health-promoting sense.

Chronic cannabis use, according to neuroimaging studies, may actually result in a blunted dopamine response or reduced dopamine synthesis capacity, particularly in heavy or long-term users. This has been linked to motivational and cognitive deficits, sometimes referred to as "amotivational syndrome." Therefore, while there is clear scientific evidence that cannabis interacts with the dopamine system, there is little support for its use to support or improve dopamine function for health purposes. Most clinical research focuses on the risks of dysregulation rather than therapeutic benefits for the dopaminergic system.

In summary, cannabis affects dopamine, but current scientific evidence does not strongly validate its use for supporting the dopamine body system in a positive or therapeutic way.

More about Cannabis
More about Dopamine

Other ingredients that support Dopamine

Other body systems supported by Cannabis

Products containing Cannabis